Gyre Therapeutics Inc GYRE

Name: Gyre Therapeutics Inc
SKU: GYRE
Price: 7.97 USD
Availability: InStock

‎$‎7.970.15(1.92%)(1D)

• Delayed prices by NASDAQ • in USD

Invest in Gyre Therapeutics Inc
Today

Create an eToro account to buy GYRE stock on a secure, user-friendly, multi-asset trading platform.

Gyre Therapeutics Inc GYRE

Buy GYRE

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

OSW

OneSpaWorld Holdings Limited

MAX

*Past performance is not an indication of future results

Jump to:

About GYRE >
How to Buy? >
Top Guides >

The Gyre Therapeutics Inc share price is rising this week.

The Gyre Therapeutics Inc share price today is ‎$‎7.97, reflecting a ‎1.92‎% change over the last 24 hours and ‎2.45‎% over the past week. The current market capitalization of GYRE is ‎$‎710.76M with an average volume in the last three months of 76210.6. The stock has a P/E ratio of 205.25 and a dividend yield of 0%. With the stock’s beta sitting at 1.37

GYRE Key Metrics

Market Cap

‎$‎710.76M

Day’s Range

‎$‎7.69 - ‎$‎8

52W Range

‎$‎6.17 - ‎$‎18.98

Average Volume (3M)

76210.6

Price-Earnings Ratio

205.25

Revenue

‎$‎107.27M

Dividend (Yield)

‎$‎0 (0%)

Prev Close

‎$‎7.97

EPS

‎$‎0.04

Beta

1.37

How can I buy Gyre Therapeutics Inc stocks?

To purchase Gyre Therapeutics Inc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Gyre Therapeutics Inc (GYRE) page and place an order to buy Gyre Therapeutics Inc.

Buy GYRE

Looking for more information? Check out our guide on Academy.

What Is Gyre Therapeutics Inc?

Gyre Therapeutics is a clinical-stage biopharmaceutical company focusing on treatments for organ fibrosis and inflammatory diseases. Based in California, the company focuses on developing and commercialising therapeutics for conditions such as Metabolic Dysfunction Associated Steatohepatitis (MASH) fibrosis and idiopathic pulmonary fibrosis.

Operating in the biopharmaceutical sector, Gyre Therapeutics has a pipeline of drug candidates, including hydronidone for MASH fibrosis and pirfenidone for various lung diseases. Through partnerships and its subsidiary Beijing Continent, Gyre has expanded its reach into China.

Diversify your virtual portfolio by following GYRE shares on eToro.

CEO

Ping Zhang, MBA

Employees

Founded

1997

San Diego, California, US

Med Tech

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Gyre Therapeutics Inc
Today

Create an eToro account to buy GYRE stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Gyre Therapeutics Inc stock?

The current price of GYRE is ‎$‎7.97.

What are analysts’ forecasts for Gyre Therapeutics Inc?

Analysts offer forecasts for Gyre Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Gyre Therapeutics Inc?

The market capitalisation of Gyre Therapeutics Inc is ‎$‎710.76M

Daily Movers

Explore the biggest stocks movers on the market.